OR WAIT null SECS
June 05, 2023
Decision is anticipated to boost operational efficiencies for the CDMO.
June 02, 2023
Company is expanding its manufacturing capacity for drug substance and drug product at its sites in Leverkusen and Wuppertal, Germany.
New PC column explores commercialization trends and how pharma can adjust to the new squeeze of market, regulatory, pricing, and gross-to-net pressures.
May 30, 2023
Company’s latest report reveals future plans, powered by efforts to divert more of its air shipments to sea.
May 24, 2023
New fill-finish plant strengthens nation’s reputation as an APAC biomedical hub.
May 19, 2023
Document reveals that 20 of 28 of participating Big Pharma manufacturers saw their DIO increase by an average of 5%, suggesting that large amounts of inventory do not necessarily offer protection from running low on medication.
May 08, 2023
The treatments span various therapeutic areas, from antibiotic to oncology.
May 05, 2023
New capability will support manufacturing of commercial-stage therapies to help combat cancers and genetic diseases.
April 25, 2023
Roundtable drills down on ways the two sectors can come together to reduce carbon emissions.
Real-time location monitoring solution allows increased visibility into the precise location of shipments in transit globally.